Immune checkpoint inhibitors for multiple myeloma immunotherapy.

"Declarations Competing interestsAll authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing of interests. Competing interests All authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing of interests."

"Funding This work was supported by the National Natural Science Foundation of China Youth Project (Grant no. 81900131,82000219), the National Natural Science Foundation of China Youth Project (Grant no. 8210010129), the Tianjin Municipal Natural Science Foundation (Grant no. 18JCQNJC80400, 19JCZDJC32900), the Tianjin Education Commission Research Project (Grant no. 2018KJ043,20140118), the Tianjin Education Commission Research Project (Grant no. 2018KJ045), the Tianjin Science and Technology Planning Project (no. 20YFZCSY00060), the Tianjin Municipal Health Commission Youth Project (Grant no. TJWJ2021QN001), Medjaden Academy & Research Foundation for Young Scientists (Grant No. MJR20221011) and the Tianjin Key Medical Discipline (Specialty) Construction project (Grant TJYXZDXK-028A)."